Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Angiotensin II Receptor Blockers
DRUG
2 trials
Sponsors
Ottawa Heart Institute Research Corporation
, Brigham and Women's Hospital
Conditions
COVID-19
Cardiovascular Diseases
Frailty
Heart Failure, Systolic
Phase 3
The COVID-RASi Trial (COVID-19)
Completed
NCT04591210
Ottawa Heart Institute Research Corporation
Cardiovascular Diseases, COVID-19
Start: 2021-01-27
End: 2024-12-30
Updated: 2026-01-28
Unknown Phase
Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty
NCT04743063
Brigham and Women's Hospital
Frailty, Heart Failure, Systolic
Start: 2021-01-14
End: 2022-12-31
Target: 40000
Updated: 2021-02-15